Measuring performance status in pediatric patients with brain tumors-experience of the HIT-GBM-C protocol
- 31 March 2010
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 55 (3) , 520-524
Abstract
Background Measuring the quality of life or performance status in pediatric neurooncology has proven a challenge. Here, we report in a treatment protocol for pediatric patients with high‐grade glioma and diffuse intrinsic pontine glioma. Procedure The Fertigkeitenskala Münster–Heidelberg (FMH) is a 56‐item quantitative measure of health status. The number of yes answers is transformed to age‐dependent percentiles. Physicians were also asked the patients' health status by their own judgment on a 1–5 scale: normal, mild handicap, age‐normal activity severely reduced but patient not in bed, in bed, and in ICU. Results Assessments were available from 50 of 97 eligible patients. For 22 patients both questionnaire and the physicians score obtained. At the beginning of the treatment, only 5 patients scored over 40 FMH%, and 4 of these survived. Of 16 patients who initially scored less than 40 FMH%, 15 died. During later assessments, most FMH measures became gradually worse. FMH scores improved in three patients. The physician's judgment was documented at diagnosis and during treatment (n = 50). Per physician, 22% of the patients were normal before chemotherapy, decreasing to 16% in the middle of the protocol. At diagnosis only 16% of patients had severely reduced activity, which increased to 30.6% in the middle of the protocol. The FMH% correlated well with the physicians' judgments (P < 0.005). Conclusion The FMH scale is easily obtained and provides a valid assessment of health status. Patients with poor performance at diagnosis had a poorer prognosis. Pediatr Blood Cancer. 2010;55:520–524.Keywords
This publication has 26 references indexed in Scilit:
- Valproic acid was well tolerated in heavily pretreated pediatric patients with high-grade gliomaJournal of Neuro-Oncology, 2008
- Subpopulations of malignant gliomas in pediatric patients: analysis of the HIT-GBM databaseJournal of Neuro-Oncology, 2008
- Maintenance treatment with interferon-gamma and low-dose cyclophosphamide for pediatric high-grade gliomaJournal of Neuro-Oncology, 2006
- Treatment options in childhood pontine gliomasJournal of Neuro-Oncology, 2006
- Treatment of paediatric pontine glioma with oral trophosphamide and etoposideBritish Journal of Cancer, 2002
- Oral trofosfamide and etoposide in pediatric patients with glioblastoma multiformeCancer, 2000
- Quantifizierung von Krankheitsfolgen in der pädiatrischen Onkologie - klinische Erfahrungen mit der Fertigkeitenskala Münster/HeidelbergKlinische Padiatrie, 1998
- The Role of Monitoring in Determining Quality of Life Following Treatment for A Bone TumorInternational Journal of Behavioral Medicine, 1997
- Children's quality of life measuresArchives of Disease in Childhood, 1997
- Fertigkeitenskala Münster Heidelberg - Ein Meßinstrument zum globalen Vergleich von KrankheitsfolgenKlinische Padiatrie, 1996